Could This Kill Cancer?

By Behar, Michael | Newsweek, November 29, 2010 | Go to article overview
Save to active project

Could This Kill Cancer?

Behar, Michael, Newsweek

Byline: Michael Behar

Why scientists are heading underwater to search for a new generation of cures.

When Hendrik Luesch invited me to Florida to go snorkeling, I didn't expect to be wading through brackish muck in the Indian River Lagoon, a 156-mile-long estuary. I'm traveling aboard a 21-foot fishing boat with Luesch, a 40-year-old associate professor of medicinal chemistry at the University of Florida in Gainesville. The visibility sucks, like swimming through a vat of kombucha. Luesch drags his fingers through the water, gathering a wad of flotsam. He raises the specimen into the sunlight to get a better look at the slime, known as cyanobacteria.

Cyanobacteria live in every ocean and on every continent in both salt and fresh water. One species causes a rash known as swimmer's itch; another blooms in lakes and reservoirs, expelling a neurotoxin that can be fatal to humans. "They produce this huge diversity of compounds that have never been identified," says Luesch, who's been studying them since 1997. Luesch has investigated cyanobacteria from around the world--Hawaii, Florida, Guam, Palau--and last year he made a startling discovery: a family of cyanobacteria called Symploca emits a toxin that attacks tumors. Luesch sprinkled Symploca extract on cultures of colon, bone, and breast-cancer cells, and they withered within hours, as though they'd been doused with Roundup; he did the same with healthy cells, and they survived virtually unscathed. Luesch christened the new compound "largazole" (the first batch came from algae near Key Largo), and has recently completed animal testing: in mice, largazole slowed the growth of cancerous colorectal tumors. He hopes to have an FDA-approved treatment on the market in about 10 years--the typical timeline to develop a new drug.

Mother Nature is a pharmacological factory. The cholesterol-lowering drug Lipitor is a cousin of red yeast rice. A species of periwinkle from Madagascar excretes a chemical for treating leukemia. Malaria is combated with quinine, originally from a rainforest tree. "About 60-plus percent of all drugs are natural products, modified natural products, or mimics of natural products," says David Newman, chief of the natural products branch at the National Cancer Institute (NCI). On land, we've already mined most of the easy targets for these compounds. Marine environments, however, have been largely ignored.

Now, advances in technology are making it easier and increasingly profitable to hunt for drugs in the ocean. Marine bioprospectors, as they're known, are scouring coral reefs, deep-sea trenches, and everything in between. Newman estimates that at least 30 research teams are experimenting with marine-derived compounds for treating cancer, neural degenerative diseases like Alzheimer's and Parkinson's, malaria, diabetes, depression, asthma, and other ailments.

Last year, Israeli scientists identified a sea sponge that contains an antibiotic for fighting a type of potentially deadly fungal infection; other researchers announced they'd found a substance in Red Sea coral that targets skin cancer. Trabectedin--a chemotherapy drug modeled after a chemical discovered in sea squirts--has been FDA approved. And just last week, the FDA also approved eribulin mesylate, a synthetic form of a substance derived from a sea sponge, to fight advanced breast cancer. About 15 more compounds are undergoing clinical trials, including an antipain medication with 100 times the potency of morphine but with no addictive potential.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Cite this article

Cited article

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Could This Kill Cancer?


Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?